EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Tumor-targeted exosomes for delivery of anticancer drugs

Rajeswari Raguraman, Dhaval Bhavsar, Dongin Kim, Xiaoyu Ren, Vassilios Sikavitsas, Anupama Munshi, Rajagopal Ramesh

Cancer Letters · 2023-04 · 558 · 216093

DOI: 10.1016/j.canlet.2023.216093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2023-04. Verfasst von Rajeswari Raguraman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA; OU Health Stephenson Cancer Center, The Un…. Hauptthemen laut MEDLINE: Exosomes, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 108-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, Presbyterian Health Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exosomes are small phospholipid bilayer vesicles that are naturally produced by all living cells, both prokaryotes and eukaryotes. The exosomes due to their unique size, reduced immunogenicity, and their ability to mimic synthetic liposomes in carrying various anticancer drugs have been tested as drug delivery vehicles for cancer treatment. An added advantage of developing exosomes as a drug carrier is the ease of manipulating their intraluminal content and their surface modification to achieve tumor-targeted drug delivery. In the past ten-years, there has been an exponential increase in the number of exosome-related studies in cancer. Preclinical studies demonstrate exosomes-mediated delivery of chemotherapeutics, biologicals and natural products produce potent anticancer activity both, in vitro and in vivo. In contrast, the number of exosome-based clinical trials are few due to challenges in the manufacturing and scalability related to large-scale production of exosomes and their storage and stability. Herein, we discuss recent advances in exosome-based drug delivery for cancer treatment in preclinical and clinical studies and conclude with challenges to be overcome for translating a larger number of exosome-based therapies into the clinic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesNeoplasmsAntineoplastic AgentsHumansDrug Delivery SystemsDrug Carriers

Stichwörter der Autor:innen

Drug deliveryExosomesExtracellular vesiclesNanomedicineTargeting

Substanzen

Drug CarriersAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA; OU Health Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104,…
  • Department of Pharmaceutical Sciences, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA; OU Health Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma Ci…
  • Department of Pharmaceutical Sciences, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
  • School of Chemical, Biological and Material Engineering, The University of Oklahoma, Norman, Oklahoma, 73019, USA; OU Health Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK…
  • Department of Radiation Oncology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA; OU Health Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, O…

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • Presbyterian Health Foundation
  • National Cancer Institute
  • U.S. Department of Defense
  • National Institutes of Health
  • Tobacco Settlement Endowment Trust
  • National Institute of General Medical Sciences

Zitieren

APA

Raguraman, R., Bhavsar, D., Kim, D., Ren, X., Sikavitsas, V., Munshi, A., & Ramesh, R. (2023). Tumor-targeted exosomes for delivery of anticancer drugs. Cancer Letters, 558, 216093. https://doi.org/10.1016/j.canlet.2023.216093

Vancouver

Raguraman R, Bhavsar D, Kim D, Ren X, Sikavitsas V, Munshi A, et al. Tumor-targeted exosomes for delivery of anticancer drugs. Cancer Letters. 2023;558:216093. doi:10.1016/j.canlet.2023.216093

BibTeX
@article{Raguraman2023,
  author = {Raguraman, Rajeswari and Bhavsar, Dhaval and Kim, Dongin and Ren, Xiaoyu and Sikavitsas, Vassilios and Munshi, Anupama and Ramesh, Rajagopal},
  title = {Tumor-targeted exosomes for delivery of anticancer drugs},
  journal = {Cancer Letters},
  year = {2023},
  volume = {558},
  pages = {216093},
  doi = {10.1016/j.canlet.2023.216093}
}
Kostenlos starten →